← SynDRA
DELAFLOXACIN
SynDRA canonical compound SYN0031514 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | antiinfective drug |
|---|
All known targets
- Malaria gyrase
- Stap-coc parC
Mechanisms of action (all sources)
- Stap-coc parC MODULATOR
- Stap-coc parC INHIBITOR
- Malaria gyrase INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ADORA1
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- KCNH2
- HTR2B
- HTR1A
- HRH3
- F2
- ESR1
- DRD3
- DRD1
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- ADORA3
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- GAMT
- GNMT
- HNMT
- NNMT
- PNMT
Drug classes
- Anti-Infective Agents
- Fluoroquinolone Antibacterial
- antiinfective drug
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
Cross-references
Synonyms
- BAXDELA
- Baxdela
- delafloxacin meglumine
- baxdela
- RX-3341
- WQ-3034
- ABT-492
- Delafloxacine
- Delafloxacino
- Delafloxacin Meglumine
- Abt 492
- ABT492
- UNII-6315412YVF
- 6315412YVF
- Delafloxacin [USAN:INN]
- Delafloxacinum
- Delafloxacin (USAN)
- WQ 3034
- delafloxacine
- delafloxacino
- RefChem:57796
- DTXCID9094822
- J01MA23
- Delafloxacin [USAN]
- MFCD09955301
- Quofenix
- C18H12ClF3N4O4
- TE9
- Abbott 492
- Delafloxacin (Standard)
- DelafloxacinABT-492?
- Delafloxacin 100 microg/mL in Acetonitrile
- DELAFLOXACIN [MI]
- Delafloxacin Impurity 48
- DELAFLOXACIN [INN]
- DELAFLOXACIN [WHO-DD]
- SCHEMBL294694
- orb1303210
Reported adverse events
- Tendinitis
- Peripheral neuropathy
- Headache
- Hypersensitivity
- Nausea
- Vomiting
- Clostridium difficile infection
Look up DELAFLOXACIN in the interactive SynDRA portal →